首页 > 最新文献

Acta microbiologica et immunologica Hungarica最新文献

英文 中文
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia. 在塞尔维亚一所大学医院的血液培养中,亚胺培南/雷巴坦和头孢他啶/阿维巴坦对碳青霉烯耐药性肺炎克雷伯菌的体外活性。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-03 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02108
Sanja Zornic, Ivana Petrovic, Bojana Lukovic

The study aimed to investigate prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) blood culture isolates and their susceptibility to two new antibiotics, imipenem/relebactam and ceftazidime/avibactam. Out of 765 isolates recovered from blood cultures in a tertiary care hospital in Serbia between 2020 and 2023, 143 non-repetitive K. pneumoniae strains were included in this study. Minimum inhibitory concentration (MIC) values of the examined antimicrobial drugs was determined by VITEK 2 system, MIC test strip (imipenem/relebactam and ceftazidime/avibactam), and broth microdilution method (tigecycline and colistin). Carbapenemase-encoding genes (blaKPC, blaOXA-48-like, blaNDM, blaVIM, blaIMP) were detected using a multiplex-PCR assay, the BioFire-Blood Culture Identification 2-panel. This closed molecular assay is designed for the BioFire® FilmArray® system, enabling automated sample preparation, amplification, detection, and analysis (bioMérieux, France). Results revealed that K. pneumoniae was the most common isolate from blood cultures in 2022. The prevalence of K. pneumoniae was about 11.6% in 2020 and 2021, while in 2022 it raised to over 30%. Also, the frequency of CRKP increased from 11.76% in 2020, through 15.29% in 2021 to 72.94% in 2022. The majority of CRKP carried blaOXA-48-like (60.0%), followed by blaKPC (16.47%), and blaNDM (8.24%) genes, while 14.12% harboured both blaOXA-48-like and blaNDM genes. Only 25.88% of CRKP isolates were resistant to ceftazidime/avibactam, while 51.76% were resistant to imipenem/relebactam and colistin. The rapid spread of CRKP is particularly concerning because therapeutic options are limited to a few antibiotics. While imipenem/relebactam and colistin showed similar antimicrobial activity against CRKP clinical isolates, ceftazidime/avibactam proved to be the most effective antibiotic.

本研究旨在调查耐碳青霉烯肺炎克雷伯菌(CRKP)血液培养分离株的流行率及其对两种新抗生素亚胺培南/雷巴坦和头孢他啶/阿维巴坦的易感性。2020年至2023年间,在塞尔维亚一家三级护理医院从血液培养中回收的765株分离株中,143株非重复性肺炎克雷伯菌被纳入本研究。用VITEK-2系统、MIC试纸条(亚胺培南/雷巴坦和头孢他啶/阿维巴坦)和肉汤微量稀释法(替加环素和粘菌素)测定受试抗菌药物的最小抑菌浓度(MIC)值。碳青霉烯酶编码基因(blaKPC、blaOXA-48-样、blaNDM、blaVIM、blaIMP)使用多重PCR检测,即BioFire血液培养鉴定2-面板进行检测。这种封闭分子分析是为BioFire®FilmArray®系统设计的,能够实现自动化的样品制备、扩增、检测和分析(bioMérieux,法国)。结果显示,肺炎克雷伯菌是2022年血液培养中最常见的分离株。肺炎克雷伯菌的患病率在2020年和2021年约为11.6%,而在2022年上升到30%以上。此外,CRKP的频率从2020年的11.76%、2021年的15.29%增加到2022年的72.94%。大多数CRKP携带blaOXA-48样基因(60.0%),其次是blaKPC(16.47%)和blaNDM(8.24%),而14.12%同时携带blaOXA-48样和blaNDM基因。只有25.88%的CRKP分离株对头孢他啶/阿维巴坦具有耐药性,而51.76%的分离株对亚胺培南/雷巴坦和粘菌素具有耐药性。CRKP的快速传播尤其令人担忧,因为治疗选择仅限于几种抗生素。亚胺培南/雷巴坦和粘菌素对CRKP临床分离株显示出相似的抗菌活性,而头孢他啶/阿维巴坦被证明是最有效的抗生素。
{"title":"In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.","authors":"Sanja Zornic,&nbsp;Ivana Petrovic,&nbsp;Bojana Lukovic","doi":"10.1556/030.2023.02108","DOIUrl":"10.1556/030.2023.02108","url":null,"abstract":"<p><p>The study aimed to investigate prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) blood culture isolates and their susceptibility to two new antibiotics, imipenem/relebactam and ceftazidime/avibactam. Out of 765 isolates recovered from blood cultures in a tertiary care hospital in Serbia between 2020 and 2023, 143 non-repetitive K. pneumoniae strains were included in this study. Minimum inhibitory concentration (MIC) values of the examined antimicrobial drugs was determined by VITEK 2 system, MIC test strip (imipenem/relebactam and ceftazidime/avibactam), and broth microdilution method (tigecycline and colistin). Carbapenemase-encoding genes (blaKPC, blaOXA-48-like, blaNDM, blaVIM, blaIMP) were detected using a multiplex-PCR assay, the BioFire-Blood Culture Identification 2-panel. This closed molecular assay is designed for the BioFire® FilmArray® system, enabling automated sample preparation, amplification, detection, and analysis (bioMérieux, France). Results revealed that K. pneumoniae was the most common isolate from blood cultures in 2022. The prevalence of K. pneumoniae was about 11.6% in 2020 and 2021, while in 2022 it raised to over 30%. Also, the frequency of CRKP increased from 11.76% in 2020, through 15.29% in 2021 to 72.94% in 2022. The majority of CRKP carried blaOXA-48-like (60.0%), followed by blaKPC (16.47%), and blaNDM (8.24%) genes, while 14.12% harboured both blaOXA-48-like and blaNDM genes. Only 25.88% of CRKP isolates were resistant to ceftazidime/avibactam, while 51.76% were resistant to imipenem/relebactam and colistin. The rapid spread of CRKP is particularly concerning because therapeutic options are limited to a few antibiotics. While imipenem/relebactam and colistin showed similar antimicrobial activity against CRKP clinical isolates, ceftazidime/avibactam proved to be the most effective antibiotic.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"187-192"},"PeriodicalIF":1.5,"publicationDate":"2023-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9924434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of oral microbiota in irreversible pulpitis - Current strategies and future perspectives. 口腔微生物群在不可逆牙髓炎中的作用——当前策略和未来展望。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-28 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02082
Preethesh Shetty, Shishir Shetty, Praveen Rai, Ballamoole Krishna Kumar, Raksha Bhat

Irreversible pulpitis is an inflammation of the tooth pulp caused by an opportunity-driven invasion of the pulp space by oral microbiota typically prevalent in the oral cavity. Microbial organisms are extensively recognised to be the fundamental cause of endodontic infections and treatment failures. Previously, bacterial species responsible for these infections were largely recognised using conventional microbial culture techniques, lending credence to the widely held belief that anaerobic Gram-negative bacteria frequently enter the pulp space and trigger endodontic infections. The advent of novel technologies grants the advantage of detecting and studying microbial populations via an amalgamation of the modern "Omics" techniques and meticulous bioinformatics analysis, additionally detecting the metatranscriptome, metaproteome and metabolome along with the metagenome. Amongst these analytical strategies, metagenomic analyses are essentially pragmatic for investigating the oral microbiome. Metagenomics favor not only assessment of microbial composition in diseased conditions, but also contributes to detection of novel, potentially pathogenic species inclusive of non-viable bacteria. The present review describes current knowledge of root canal microbiome, including its composition and functional attributes, the novel strategies available for detection of microbiome as well as challenges associated and provides some crucial pointers for areas of future research.

不可逆性牙髓炎是一种牙髓炎症,由口腔中常见的口腔微生物群对牙髓间隙的机会驱动的入侵引起。微生物被广泛认为是牙髓病感染和治疗失败的根本原因。以前,使用传统的微生物培养技术在很大程度上识别出了导致这些感染的细菌种类,这证明了人们普遍认为厌氧革兰氏阴性菌经常进入牙髓间隙并引发牙髓感染。新技术的出现赋予了通过融合现代“奥密克戎”技术和细致的生物信息学分析来检测和研究微生物种群的优势,此外还检测了元转录组、元蛋白质组和代谢组以及元基因组。在这些分析策略中,宏基因组分析对于研究口腔微生物组基本上是实用的。宏基因组学不仅有利于评估患病条件下的微生物组成,而且有助于检测包括不活细菌在内的新的潜在致病物种。本综述描述了根管微生物组的现有知识,包括其组成和功能属性、可用于检测微生物组的新策略以及相关挑战,并为未来的研究领域提供了一些重要的指导。
{"title":"Role of oral microbiota in irreversible pulpitis - Current strategies and future perspectives.","authors":"Preethesh Shetty,&nbsp;Shishir Shetty,&nbsp;Praveen Rai,&nbsp;Ballamoole Krishna Kumar,&nbsp;Raksha Bhat","doi":"10.1556/030.2023.02082","DOIUrl":"10.1556/030.2023.02082","url":null,"abstract":"<p><p>Irreversible pulpitis is an inflammation of the tooth pulp caused by an opportunity-driven invasion of the pulp space by oral microbiota typically prevalent in the oral cavity. Microbial organisms are extensively recognised to be the fundamental cause of endodontic infections and treatment failures. Previously, bacterial species responsible for these infections were largely recognised using conventional microbial culture techniques, lending credence to the widely held belief that anaerobic Gram-negative bacteria frequently enter the pulp space and trigger endodontic infections. The advent of novel technologies grants the advantage of detecting and studying microbial populations via an amalgamation of the modern \"Omics\" techniques and meticulous bioinformatics analysis, additionally detecting the metatranscriptome, metaproteome and metabolome along with the metagenome. Amongst these analytical strategies, metagenomic analyses are essentially pragmatic for investigating the oral microbiome. Metagenomics favor not only assessment of microbial composition in diseased conditions, but also contributes to detection of novel, potentially pathogenic species inclusive of non-viable bacteria. The present review describes current knowledge of root canal microbiome, including its composition and functional attributes, the novel strategies available for detection of microbiome as well as challenges associated and provides some crucial pointers for areas of future research.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"177-186"},"PeriodicalIF":1.5,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10246313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of carbapenem resistant Pseudomonas aeruginosa co-harboring blaVIM-2 and blaGES-5 in burn patients. 烧伤患者中携带blaVIM-2和blaGES-5的碳青霉烯耐药性铜绿假单胞菌的检测。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-25 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02089
Souhir Hmissi, Anis Raddaoui, Siwar Frigui, Mohamed Salah Abbassi, Wafa Achour, Yosra Chebbi, Lamia Thabet

Pseudomonas aeruginosa is one of the major infectious agents in burn patients. Globally, high rates of antimicrobial resistance in P. aeruginosa have been reported, which is a cause of concern. The objective of this study was to determine the rate of resistance to carbapenems in P. aeruginosa isolates recovered from burn patients in Tunisia, to search genes encoding for carbapenemases and to determine their epidemiological markers (serotypes). A retrospective study was conducted in the Burn Intensive Care Unit (BICU) of the Trauma and Burn Centre of Ben Arous, Tunisia, and P. aeruginosa isolates collected from burn patients, from January to December 2018 were investigated. Carbapenemase screening was performed by Carbapenem Inactivation Method (CIM) and by EDTA-disk test for all carbapenem resistant isolates. Genes encoding carbapenemases (blaVIM, blaIMP, blaGES, blaNDM, and blaKPC) were investigated by PCR and selected carbapenemase genes were sequenced. During the study period, 104 non duplicated P. aeruginosa isolates were recovered. Most of them were isolated from skin samples (45.1%) and blood culture (22.1%) and belonged to O:11 (19.2%), O:12, and O:5 (12.5%, each) serotypes. High rates of resistance were observed for carbapenems (64.4%). Among the 67 carbapenem resistant isolates, 58 (86.5%) harbored blaVIM gene and 55 (82%) blaGES gene; in addition, 48 (71.6%) co-harbored blaVIM and blaGES genes. After sequencing, the blaVIM-2 and blaGES-5 gene variants were identified in seven randomly selected isolates. To the best of our knowledge, this is the first description of P. aeruginosa simultaneously harboring blaVIM-2 and blaGES-5 genes.

铜绿假单胞菌是烧伤病人的主要传染源之一。在全球范围内,铜绿假单胞菌的抗微生物耐药性很高,这是一个令人担忧的原因。本研究的目的是确定突尼斯烧伤患者康复的铜绿假单胞菌分离株对碳青霉烯类的耐药性,寻找碳青霉烯酶的编码基因,并确定其流行病学标志物(血清型)。在突尼斯Ben Arous创伤和烧伤中心的烧伤重症监护室(BICU)进行了一项回顾性研究,并对2018年1月至12月从烧伤患者中收集的铜绿假单胞菌进行了调查。采用碳青霉烯灭活法(CIM)和EDTA圆盘试验对所有碳青霉烯耐药菌株进行碳青霉烯酶筛选。通过PCR研究编码碳青霉烯酶的基因(blaVIM、blaIMP、blaGES、blaNDM和blaKPC),并对所选择的碳青霉烯酶类基因进行测序。在研究期间,回收了104个非重复的铜绿假单胞菌分离株。它们大多是从皮肤样本(45.1%)和血液培养物(22.1%)中分离出来的,属于O:11(19.2%)、O:12和O:5(各12.5%)血清型。67株碳青霉烯类耐药菌株中,58株(86.5%)携带blaVIM基因,55株(82%)携带blaGES基因;此外,共有48个(71.6%)携带blaVIM和blaGES基因。测序后,在7个随机选择的分离株中鉴定出blaVIM-2和blaGES-5基因变体。据我们所知,这是首次描述同时携带blaVIM-2和blaGES-5基因的铜绿假单胞菌。
{"title":"Detection of carbapenem resistant Pseudomonas aeruginosa co-harboring blaVIM-2 and blaGES-5 in burn patients.","authors":"Souhir Hmissi,&nbsp;Anis Raddaoui,&nbsp;Siwar Frigui,&nbsp;Mohamed Salah Abbassi,&nbsp;Wafa Achour,&nbsp;Yosra Chebbi,&nbsp;Lamia Thabet","doi":"10.1556/030.2023.02089","DOIUrl":"10.1556/030.2023.02089","url":null,"abstract":"<p><p>Pseudomonas aeruginosa is one of the major infectious agents in burn patients. Globally, high rates of antimicrobial resistance in P. aeruginosa have been reported, which is a cause of concern. The objective of this study was to determine the rate of resistance to carbapenems in P. aeruginosa isolates recovered from burn patients in Tunisia, to search genes encoding for carbapenemases and to determine their epidemiological markers (serotypes). A retrospective study was conducted in the Burn Intensive Care Unit (BICU) of the Trauma and Burn Centre of Ben Arous, Tunisia, and P. aeruginosa isolates collected from burn patients, from January to December 2018 were investigated. Carbapenemase screening was performed by Carbapenem Inactivation Method (CIM) and by EDTA-disk test for all carbapenem resistant isolates. Genes encoding carbapenemases (blaVIM, blaIMP, blaGES, blaNDM, and blaKPC) were investigated by PCR and selected carbapenemase genes were sequenced. During the study period, 104 non duplicated P. aeruginosa isolates were recovered. Most of them were isolated from skin samples (45.1%) and blood culture (22.1%) and belonged to O:11 (19.2%), O:12, and O:5 (12.5%, each) serotypes. High rates of resistance were observed for carbapenems (64.4%). Among the 67 carbapenem resistant isolates, 58 (86.5%) harbored blaVIM gene and 55 (82%) blaGES gene; in addition, 48 (71.6%) co-harbored blaVIM and blaGES genes. After sequencing, the blaVIM-2 and blaGES-5 gene variants were identified in seven randomly selected isolates. To the best of our knowledge, this is the first description of P. aeruginosa simultaneously harboring blaVIM-2 and blaGES-5 genes.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"199-205"},"PeriodicalIF":1.5,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10228654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Molecular epidemiology and characterization of endemic, epidemic and imported hepatitis A virus (HAV) strains in Hungary (2003-2022). 匈牙利地方性、流行性和输入性甲型肝炎病毒株的分子流行病学和特征(2003-2022)。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-25 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02099
Gábor Reuter, Ákos Boros, Péter Pankovics

Hepatitis A virus (HAV) is one of the most important etiological agents of acute viral hepatitis but comprehensive molecular epidemiological study with chrono-phylogeographical data are not available from Hungary.Between 2003 and 2022, a total of 8,307 HAV infections were registered officially in Hungary of which 400 (4.8%) HAV IgM antibody-positive serum samples were collected countrywide. HAV genomic RNA was successfully detected in 216/400 (54%) sera by RT-PCR subsequently confirmed by sequencing. The complete nucleotide sequences of VP1 region were determined in 32 representative HAV strains. Based on the sequence analysis, 150 (69.4%) strains were characterized as HAV sub-genotype IA and 66 (30.6%) as sub-genotype IB, respectively. Based on the combined epidemiological and molecular data, epidemic, endemic, and imported HAV strains were also characterized. The first two registered countrywide outbreaks started among men-sex-with men (MSM) in 2011 (sub-genotype IA) and 2021 (sub-genotype IB), the continuously circulating endemic/domestic HAV strain (sub-genotype IA) in East Hungary and the travel-related sub-genotype IB strains from Egypt should be highlighted. All HAV strains are deposited in the HAVNET database (https://www.rivm.nl/en/havnet).In this 20-year-long comprehensive molecular epidemiological study, we report the genetic characterization and geographic distribution of endemic, epidemic and imported HAV strains for the first time in Hungary with continuous co-circulation of sub-genotypes IA and IB HAV strains since 2003. These data provide basic information about the HAV situation in the country in an international context and can promote more effective national public health intervention strategies for the prevention of HAV transmissions and infections.

甲型肝炎病毒(HAV)是急性病毒性肝炎最重要的病因之一,但匈牙利没有具有时间系统地理数据的全面分子流行病学研究。2003年至2022年间,匈牙利共正式登记了8307例HAV感染者,其中全国共收集了400份(4.8%)HAV-IgM抗体阳性血清样本。通过RT-PCR在216/400份(54%)血清中成功检测到HAV基因组RNA,随后通过测序证实。在32株具有代表性的甲型肝炎病毒株中测定了VP1区的完整核苷酸序列。序列分析表明,150株(69.4%)为甲型肝炎病毒亚型IA,66株(30.6%)为亚型IB。根据流行病学和分子数据,还对流行性、地方性和输入性甲型肝炎病毒株进行了表征。2011年(亚型IA)和2021年(亚基因型IB),在全国范围内登记的前两起疫情始于男男性行为者(MSM),应强调东匈牙利持续传播的地方性/国内甲型肝炎病毒株(亚型IA)和来自埃及的旅行相关亚型IB株。所有甲型肝炎病毒株都保存在甲型肝炎病毒网数据库中(https://www.rivm.nl/en/havnet)在这项长达20年的综合分子流行病学研究中,我们首次报道了匈牙利地方性、流行性和输入性甲型肝炎病毒株的遗传特征和地理分布,自2003年以来,亚基因型IA和IB型甲型肝炎病毒毒株持续共流。这些数据在国际范围内提供了有关该国甲型肝炎病毒状况的基本信息,可以促进更有效的国家公共卫生干预战略,以预防甲型肝炎病毒传播和感染。
{"title":"Molecular epidemiology and characterization of endemic, epidemic and imported hepatitis A virus (HAV) strains in Hungary (2003-2022).","authors":"Gábor Reuter,&nbsp;Ákos Boros,&nbsp;Péter Pankovics","doi":"10.1556/030.2023.02099","DOIUrl":"10.1556/030.2023.02099","url":null,"abstract":"<p><p>Hepatitis A virus (HAV) is one of the most important etiological agents of acute viral hepatitis but comprehensive molecular epidemiological study with chrono-phylogeographical data are not available from Hungary.Between 2003 and 2022, a total of 8,307 HAV infections were registered officially in Hungary of which 400 (4.8%) HAV IgM antibody-positive serum samples were collected countrywide. HAV genomic RNA was successfully detected in 216/400 (54%) sera by RT-PCR subsequently confirmed by sequencing. The complete nucleotide sequences of VP1 region were determined in 32 representative HAV strains. Based on the sequence analysis, 150 (69.4%) strains were characterized as HAV sub-genotype IA and 66 (30.6%) as sub-genotype IB, respectively. Based on the combined epidemiological and molecular data, epidemic, endemic, and imported HAV strains were also characterized. The first two registered countrywide outbreaks started among men-sex-with men (MSM) in 2011 (sub-genotype IA) and 2021 (sub-genotype IB), the continuously circulating endemic/domestic HAV strain (sub-genotype IA) in East Hungary and the travel-related sub-genotype IB strains from Egypt should be highlighted. All HAV strains are deposited in the HAVNET database (https://www.rivm.nl/en/havnet).In this 20-year-long comprehensive molecular epidemiological study, we report the genetic characterization and geographic distribution of endemic, epidemic and imported HAV strains for the first time in Hungary with continuous co-circulation of sub-genotypes IA and IB HAV strains since 2003. These data provide basic information about the HAV situation in the country in an international context and can promote more effective national public health intervention strategies for the prevention of HAV transmissions and infections.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"246-251"},"PeriodicalIF":1.5,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10228652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of colistin resistant Acinetobacter baumannii clonal complex 2 (CC2) among hospitalized patients in Iran. 伊朗住院患者中出现耐粘菌素鲍曼不动杆菌克隆复合物2(CC2)。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-24 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02057
Bahareh Hajihashemi, Ali Abbasi, Dariush Shokri

Acinetobacter baumannii is a major causative agent of serious nosocomial infections. This study was carried out to investigate the molecular characterization of colistin resistant isolates of A. baumannii from hospitalized patients, based on multilocus sequence typing (MLST). A cross-sectional study was conducted to collect A. baumannii from clinical samples in Isfahan from 2021 to 2022. Isolates were identified as A. baumannii using biochemical tests and PCR of blaOXA-51. Antibiotic susceptibility testing was carried out using the Kirby-Bauer method and minimum inhibitory concentration (MIC) values were determined for colistin. Additionally, MLST was performed according to the Pasteur scheme to assess the relationship between colistin resistant A. baumannii. A total of 70 non-repetitive A. baumannii isolates were obtained from different clinical samples. MIC results showed that seven A. baumannii isolates were resistant to colistin. The antibiotic susceptibility pattern revealed that all seven colistin resistant strains were resistant to all tested antibiotics. Based on MLST analysis, the colistin resistant isolates were assigned to five unique STs namely, ST2 (3; 42.9%) followed by ST78 (1; 14.3%), ST1077 (1; 14.3%), ST415 (1; 14.3%) and ST391 (1; 14.3%). Among them ST2, ST391 and ST415 belong to clonal complex 2. Colistin resistant A. baumannii ST2 is the main circulating clone in clinical settings in Iran, but additionally ST415, ST391, and ST1077 are found for the first time in our country. Intensive control procedures and strict adherence to surveillance programs are recommended to decrease the spread of carbapenem and colistin resistant A. baumannii strain.

鲍曼不动杆菌是严重医院感染的主要病原体。本研究基于多点序列分型(MLST),对住院患者中的鲍曼不动杆菌粘菌素耐药性分离株的分子特征进行了研究。进行了一项横断面研究,从2021年至2022年伊斯法罕的临床样本中采集鲍曼不动杆菌。通过生化测试和blaOXA-51的PCR鉴定分离物为鲍曼不动杆菌。使用Kirby-Bauer方法进行抗生素敏感性测试,并测定粘菌素的最小抑制浓度(MIC)值。此外,根据巴斯德方案进行MLST,以评估粘菌素耐药性鲍曼不动杆菌之间的关系。从不同的临床样本中共获得70个非重复性鲍曼不动杆菌分离株。MIC结果显示,7株鲍曼不动杆菌对粘菌素具有耐药性。抗生素敏感性模式显示,所有7株粘菌素耐药菌株对所有测试的抗生素都有耐药性。根据MLST分析,将粘菌素抗性菌株分为5个独特的ST,即ST2(3;42.9%),其次是ST78(1;14.3%),ST1077(1;14.3%),ST 415(1;143%)和ST391(1;14.6%),其中ST2,ST391和ST415属于克隆复合体2。耐大肠杆菌素的鲍曼氏杆菌ST2是伊朗临床上主要的循环克隆,但在我国还首次发现了ST415、ST391和ST1077。建议加强控制程序并严格遵守监测计划,以减少碳青霉烯和粘菌素耐药性鲍曼不动杆菌菌株的传播。
{"title":"Emergence of colistin resistant Acinetobacter baumannii clonal complex 2 (CC2) among hospitalized patients in Iran.","authors":"Bahareh Hajihashemi,&nbsp;Ali Abbasi,&nbsp;Dariush Shokri","doi":"10.1556/030.2023.02057","DOIUrl":"10.1556/030.2023.02057","url":null,"abstract":"<p><p>Acinetobacter baumannii is a major causative agent of serious nosocomial infections. This study was carried out to investigate the molecular characterization of colistin resistant isolates of A. baumannii from hospitalized patients, based on multilocus sequence typing (MLST). A cross-sectional study was conducted to collect A. baumannii from clinical samples in Isfahan from 2021 to 2022. Isolates were identified as A. baumannii using biochemical tests and PCR of blaOXA-51. Antibiotic susceptibility testing was carried out using the Kirby-Bauer method and minimum inhibitory concentration (MIC) values were determined for colistin. Additionally, MLST was performed according to the Pasteur scheme to assess the relationship between colistin resistant A. baumannii. A total of 70 non-repetitive A. baumannii isolates were obtained from different clinical samples. MIC results showed that seven A. baumannii isolates were resistant to colistin. The antibiotic susceptibility pattern revealed that all seven colistin resistant strains were resistant to all tested antibiotics. Based on MLST analysis, the colistin resistant isolates were assigned to five unique STs namely, ST2 (3; 42.9%) followed by ST78 (1; 14.3%), ST1077 (1; 14.3%), ST415 (1; 14.3%) and ST391 (1; 14.3%). Among them ST2, ST391 and ST415 belong to clonal complex 2. Colistin resistant A. baumannii ST2 is the main circulating clone in clinical settings in Iran, but additionally ST415, ST391, and ST1077 are found for the first time in our country. Intensive control procedures and strict adherence to surveillance programs are recommended to decrease the spread of carbapenem and colistin resistant A. baumannii strain.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"213-219"},"PeriodicalIF":1.5,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9862551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of NDM-1 and IMP-8 carbapenemase producing Raoultella planticola clinical isolates. NDM-1和IMP-8产碳青霉烯酶植物拉乌尔氏菌临床分离株的分析。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-21 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02078
Qingyu Wang, Xinyi Wang, Chunling Chen, Li Zhao, Jie Ma, Kai Dong

Object of our study was to analyze the carriage of resistance genes in carbapenem-resistant Raoultella planticola (CRRP) by whole genome sequencing (WGS). Three strains of CRRP (named WF0027, WF3597 and WF3648) were collected for clinical analysis and susceptibility of antimicrobial agents was determined. The WGS of three strains was done by Illumina platform and strain identification was performed by average nucleotide identity, and the antibiotic resistance genes carried by the three strains were detected by ABRicate software. Whole genome data of 46 CRRP strains were downloaded from the National Center for Biotechnology Information (NCBI) database, and the evolutionary tree was constructed by genomic single nucleotide polymorphism together with this study strains. Antimicrobial susceptibility testing revealed that WF3597 and WF3648 were susceptible to tigecycline and colistin, while exhibited resistance to 24 antimicrobial agents. WF0027 was resistant to 18 antimicrobial agents. A total of 25 resistance genes were identified using ABRicate software. WF0027 carried blaIMP-8, whereas WF3597 and WF3648 carried blaNDM-1 carbapenem resistance gene. As predicted by the PlasmidFinder, WF3597 and WF3648 carried one plasmid IncFII(p14)_1_p14, whereas WF0027 carried five plasmids. Evolutionary tree results show all strains are clustered into six groups, the strains WF3597 and WF3648 belonged to the same evolutionary group (E clade) and WF0027 belonged to the F clade. Three CRRP strains in our study carried carbapenem resistance genes (blaNDM-1 or blaIMP-8) and were resistant to multiple antimicrobial agents, posing a significant challenge for clinical treatment.

本研究的目的是通过全基因组测序(WGS)分析碳青霉烯抗性植物拉乌尔氏菌(CRRP)的抗性基因携带情况。收集3株CRRP(命名为WF0027、WF3597和WF3648)进行临床分析,并测定其对抗菌药物的敏感性。利用Illumina平台对3株菌株进行WGS检测,利用平均核苷酸同一性进行菌株鉴定,并利用ABRITE软件检测3株菌株携带的抗生素抗性基因。从国家生物技术信息中心(NCBI)数据库下载了46株CRRP菌株的全基因组数据,并与本研究菌株一起通过基因组单核苷酸多态性构建了进化树。抗菌药敏试验显示,WF3597和WF3648对替加环素和粘菌素敏感,对24种抗菌药物表现出耐药性。WF0027对18种抗菌药物具有耐药性。利用ABRITE软件共鉴定出25个抗性基因。WF0027携带blaIMP-8,而WF3597和WF3648携带blaNDM-1碳青霉烯抗性基因。如PlasmidFinder所预测的,WF3597和WF3648携带一个质粒IncFII(p14)_1_p14,而WF0027携带五个质粒。进化树结果表明,菌株WF3597和WF3648属于同一进化群(E分支),WF0027属于F分支。我们研究中的三株CRRP菌株携带碳青霉烯类耐药基因(blaNDM-1或blaIMP-8),对多种抗菌药物具有耐药性,这对临床治疗构成了重大挑战。
{"title":"Analysis of NDM-1 and IMP-8 carbapenemase producing Raoultella planticola clinical isolates.","authors":"Qingyu Wang,&nbsp;Xinyi Wang,&nbsp;Chunling Chen,&nbsp;Li Zhao,&nbsp;Jie Ma,&nbsp;Kai Dong","doi":"10.1556/030.2023.02078","DOIUrl":"10.1556/030.2023.02078","url":null,"abstract":"<p><p>Object of our study was to analyze the carriage of resistance genes in carbapenem-resistant Raoultella planticola (CRRP) by whole genome sequencing (WGS). Three strains of CRRP (named WF0027, WF3597 and WF3648) were collected for clinical analysis and susceptibility of antimicrobial agents was determined. The WGS of three strains was done by Illumina platform and strain identification was performed by average nucleotide identity, and the antibiotic resistance genes carried by the three strains were detected by ABRicate software. Whole genome data of 46 CRRP strains were downloaded from the National Center for Biotechnology Information (NCBI) database, and the evolutionary tree was constructed by genomic single nucleotide polymorphism together with this study strains. Antimicrobial susceptibility testing revealed that WF3597 and WF3648 were susceptible to tigecycline and colistin, while exhibited resistance to 24 antimicrobial agents. WF0027 was resistant to 18 antimicrobial agents. A total of 25 resistance genes were identified using ABRicate software. WF0027 carried blaIMP-8, whereas WF3597 and WF3648 carried blaNDM-1 carbapenem resistance gene. As predicted by the PlasmidFinder, WF3597 and WF3648 carried one plasmid IncFII(p14)_1_p14, whereas WF0027 carried five plasmids. Evolutionary tree results show all strains are clustered into six groups, the strains WF3597 and WF3648 belonged to the same evolutionary group (E clade) and WF0027 belonged to the F clade. Three CRRP strains in our study carried carbapenem resistance genes (blaNDM-1 or blaIMP-8) and were resistant to multiple antimicrobial agents, posing a significant challenge for clinical treatment.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"193-198"},"PeriodicalIF":1.5,"publicationDate":"2023-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9850829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece. 诺卡氏病的临床和微生物学特征:希腊克里特岛一项为期5年的单中心研究。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-17 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02071
Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Dimitra Stafylaki, Effie Scoulica

Nocardiosis is a rare disease affecting both immunocompromised and immunocompetent hosts, presented in various clinical forms ranging from localized to disseminated infection. Aim of the present study was to investigate the clinical and microbiological characteristics of nocardiosis, antimicrobial resistance profiles, treatment, and outcomes of Nocardia infection over the last 5 years at our institution. The medical records and microbiological data of patients affected by nocardiosis and treated at the university hospital of Heraklion, Crete, Greece, between 2018 and 2022, were retrospectively analyzed. The isolates were identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and through sequencing of 16S rRNA. Antimicrobial susceptibility for 17 agents was determined by E-test and results were interpreted according to CLSI guidelines. Among the 28 Nocardia isolates, eight species were identified, with Nocardia brasiliensis being the most prevalent (32.1%), followed by Nocardia otitidiscaviarum (25%), and Nocardia farcinica (14.3%). Skin and soft tissue infections were the most common presentations, noted in 13 (50%) patients, followed by pulmonary infection presented in 10 (38.5%) patients. Fifteen patients (57.7%) had at least one underlying disease, and 11 (42.3%) were on immunosuppressive or long-term corticosteroid treatment. Susceptibility rates of linezolid, tigecycline, amikacin, trimethoprim-sulfamethoxazole, moxifloxacin, and imipenem were 100, 100, 96.4, 92.9, 82.1, and 42.9%, respectively. The 26 patients in this study were treated with various antibiotics. Mortality rate was 3.8%, and the patient who died had disseminated infection. Since epidemiology and antimicrobial susceptibility are evolving, continuous surveillance is mandatory in order to initiate appropriate treatment in a timely manner.

Nocardiosis是一种罕见的疾病,既影响免疫功能低下的宿主,也影响免疫功能强大的宿主,表现为从局限性感染到播散性感染的各种临床形式。本研究的目的是调查诺卡氏菌病的临床和微生物学特征、过去5年来诺卡氏病感染的耐药性、治疗和结果。回顾性分析了2018年至2022年间在希腊克里特岛伊拉克利翁大学医院接受治疗的诺卡病患者的医疗记录和微生物学数据。分离物通过基质辅助激光解吸电离飞行时间质谱法(MALDI-TOF MS)和16S rRNA测序进行鉴定。通过E试验测定17种药物的耐药性,并根据CLSI指南对结果进行解释。在28个诺卡氏菌分离株中,鉴定出8个种,其中巴西诺卡氏杆菌最为常见(32.1%),其次是奥蒂斯卡维亚诺卡氏球菌(25%)和法氏诺卡氏菌株(14.3%)。皮肤和软组织感染是最常见的表现,13例(50%)患者出现,10例(38.5%)患者出现肺部感染。15名患者(57.7%)至少有一种潜在疾病,11名患者(42.3%)正在接受免疫抑制或长期皮质类固醇治疗。利奈唑胺、替加环素、阿米卡星、甲氧苄啶-磺胺甲恶唑、莫西沙星和亚胺培南的敏感率分别为100、100、96.4、92.9、82.1和42.9%。本研究中的26名患者接受了各种抗生素治疗。死亡率为3.8%,死亡患者为播散性感染。由于流行病学和抗菌药物易感性正在演变,因此必须进行持续监测,以便及时开始适当的治疗。
{"title":"Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece.","authors":"Sofia Maraki,&nbsp;Viktoria Eirini Mavromanolaki,&nbsp;Anna Kasimati,&nbsp;Dimitra Stafylaki,&nbsp;Effie Scoulica","doi":"10.1556/030.2023.02071","DOIUrl":"10.1556/030.2023.02071","url":null,"abstract":"<p><p>Nocardiosis is a rare disease affecting both immunocompromised and immunocompetent hosts, presented in various clinical forms ranging from localized to disseminated infection. Aim of the present study was to investigate the clinical and microbiological characteristics of nocardiosis, antimicrobial resistance profiles, treatment, and outcomes of Nocardia infection over the last 5 years at our institution. The medical records and microbiological data of patients affected by nocardiosis and treated at the university hospital of Heraklion, Crete, Greece, between 2018 and 2022, were retrospectively analyzed. The isolates were identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and through sequencing of 16S rRNA. Antimicrobial susceptibility for 17 agents was determined by E-test and results were interpreted according to CLSI guidelines. Among the 28 Nocardia isolates, eight species were identified, with Nocardia brasiliensis being the most prevalent (32.1%), followed by Nocardia otitidiscaviarum (25%), and Nocardia farcinica (14.3%). Skin and soft tissue infections were the most common presentations, noted in 13 (50%) patients, followed by pulmonary infection presented in 10 (38.5%) patients. Fifteen patients (57.7%) had at least one underlying disease, and 11 (42.3%) were on immunosuppressive or long-term corticosteroid treatment. Susceptibility rates of linezolid, tigecycline, amikacin, trimethoprim-sulfamethoxazole, moxifloxacin, and imipenem were 100, 100, 96.4, 92.9, 82.1, and 42.9%, respectively. The 26 patients in this study were treated with various antibiotics. Mortality rate was 3.8%, and the patient who died had disseminated infection. Since epidemiology and antimicrobial susceptibility are evolving, continuous surveillance is mandatory in order to initiate appropriate treatment in a timely manner.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"239-245"},"PeriodicalIF":1.5,"publicationDate":"2023-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10203468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genotypic and phenotypic insights into virulence factors of nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria (2011-2022). 保加利亚收集的医院嗜麦芽窄食单胞菌分离株毒力因子的基因型和表型见解(2011-2022)。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-07-04 Print Date: 2023-09-21 DOI: 10.1556/030.2023.02059
Tanya Strateva, Angelina Trifonova, Alexander Stratev, Slavil Peykov

The present study aimed to explore the virulence characteristics in 221 Bulgarian nosocomial Stenotrophomonas maltophilia isolates (2011-2022) via screening for the presence of virulence genes, their mutational variability, and the corresponding enzyme activity. PCR amplification, enzymatic assays, whole-genome sequencing (WGS), and biofilm quantification on a polystyrene plate were performed. The incidence of virulence determinants was as follows: stmPr1 (encoding for the major extracellular protease StmPr1) 87.3%, stmPr2 (minor extracellular protease StmPr2) 99.1%, Smlt3773 locus (outer membrane esterase) 98.2%, plcN1 (non-hemolytic phospholipase C) 99.1%, and smf-1 (type-1 fimbriae, biofilm-related gene) 96.4%. The 1621-bp allele of stmPr1 was most frequently found (61.1%), followed by the combined allelic variant (17.6%), stmPr1-negative genotype (12.7%), and 868-bp allele (8.6%). Protease, esterase, and lecithinase activity was observed in 95%, 98.2%, and 17.2% of the isolates, respectively. The WGS-subjected isolates (n = 9) formed two groups. Five isolates possessed only the 1621-bp variant of stmPr1, higher biofilm formation ability (Optical Density at λ = 550 nm (OD550): 1.253-1.789), as well as a low number of mutations in the protease genes and smf-1. Three other isolates had only the 868-bp variant, weaker biofilm production (OD550: 0.788-1.108), and higher number of mutations within these genes. The only weak biofilm producer (OD550 = 0.177) had no stmPr1 alleles. In conclusion, the similar PCR detection rates did not allow differentiation of the isolates. In contrast, WGS permitted stmPr1 alleles-based differentiation. To the best of our knowledge, this is the first Bulgarian study presenting genotypic and phenotypic insights into virulence factors of S. maltophilia isolates.

本研究旨在通过筛选毒力基因的存在、突变变异性和相应的酶活性,探讨221株保加利亚医院嗜麦芽窄食单胞菌(2011-2022)的毒力特征。在聚苯乙烯板上进行PCR扩增、酶测定、全基因组测序(WGS)和生物膜定量。毒力决定簇的发生率如下:stmPr1(编码主要细胞外蛋白酶stmPr1)87.3%,stmPr2(次要细胞外蛋白酶stmPr2)99.1%,Smlt3773基因座(外膜酯酶)98.2%,plcN1(非溶血性磷脂酶C)99.1%和smf-1(1型菌毛,生物膜相关基因)96.4%,其次是组合等位基因变体(17.6%)、stmPr1阴性基因型(12.7%)和868bp等位基因(8.6%)。蛋白酶、酯酶和卵磷脂酶活性分别为95%、98.2%和17.2%。经WGS处理的分离物(n=9)形成两组。5个分离株仅具有1621bp的stmPr1变体,具有更高的生物膜形成能力(λ=550nm(OD550)下的光密度:1.253-1.789),以及蛋白酶基因和smf-1的少量突变。其他三个分离株只有868bp的变体,生物膜产生较弱(OD550:0.788-1.108),这些基因中的突变数量较高。唯一的弱生物膜生产者(OD550=0.177)没有stmPr1等位基因。总之,相似的PCR检测率不允许分离物的分化。相反,WGS允许基于stmPr1等位基因的分化。据我们所知,这是保加利亚首次对嗜麦芽链球菌分离株的毒力因子进行基因型和表型研究。
{"title":"Genotypic and phenotypic insights into virulence factors of nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria (2011-2022).","authors":"Tanya Strateva,&nbsp;Angelina Trifonova,&nbsp;Alexander Stratev,&nbsp;Slavil Peykov","doi":"10.1556/030.2023.02059","DOIUrl":"10.1556/030.2023.02059","url":null,"abstract":"<p><p>The present study aimed to explore the virulence characteristics in 221 Bulgarian nosocomial Stenotrophomonas maltophilia isolates (2011-2022) via screening for the presence of virulence genes, their mutational variability, and the corresponding enzyme activity. PCR amplification, enzymatic assays, whole-genome sequencing (WGS), and biofilm quantification on a polystyrene plate were performed. The incidence of virulence determinants was as follows: stmPr1 (encoding for the major extracellular protease StmPr1) 87.3%, stmPr2 (minor extracellular protease StmPr2) 99.1%, Smlt3773 locus (outer membrane esterase) 98.2%, plcN1 (non-hemolytic phospholipase C) 99.1%, and smf-1 (type-1 fimbriae, biofilm-related gene) 96.4%. The 1621-bp allele of stmPr1 was most frequently found (61.1%), followed by the combined allelic variant (17.6%), stmPr1-negative genotype (12.7%), and 868-bp allele (8.6%). Protease, esterase, and lecithinase activity was observed in 95%, 98.2%, and 17.2% of the isolates, respectively. The WGS-subjected isolates (n = 9) formed two groups. Five isolates possessed only the 1621-bp variant of stmPr1, higher biofilm formation ability (Optical Density at λ = 550 nm (OD550): 1.253-1.789), as well as a low number of mutations in the protease genes and smf-1. Three other isolates had only the 868-bp variant, weaker biofilm production (OD550: 0.788-1.108), and higher number of mutations within these genes. The only weak biofilm producer (OD550 = 0.177) had no stmPr1 alleles. In conclusion, the similar PCR detection rates did not allow differentiation of the isolates. In contrast, WGS permitted stmPr1 alleles-based differentiation. To the best of our knowledge, this is the first Bulgarian study presenting genotypic and phenotypic insights into virulence factors of S. maltophilia isolates.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"220-230"},"PeriodicalIF":1.5,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9812017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts of the Annual Meeting of the Hungarian Society for Microbiology and the XV. Fermentation Colloquium 匈牙利微生物学会和第十五届微生物学会年会摘要。发酵讨论会
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-06-27 DOI: 10.1556/030.70.2023.001
{"title":"Abstracts of the Annual Meeting of the Hungarian Society for Microbiology and the XV. Fermentation Colloquium","authors":"","doi":"10.1556/030.70.2023.001","DOIUrl":"https://doi.org/10.1556/030.70.2023.001","url":null,"abstract":"","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":"1 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43161278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts of the 19th International Congress of the Hungarian Society for Microbiology 第十九届匈牙利微生物学会国际大会摘要
4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-06-27 DOI: 10.1556/030.70.2023.002
{"title":"Abstracts of the 19th International Congress of the Hungarian Society for Microbiology","authors":"","doi":"10.1556/030.70.2023.002","DOIUrl":"https://doi.org/10.1556/030.70.2023.002","url":null,"abstract":"","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":"247 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135359831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Acta microbiologica et immunologica Hungarica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1